Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Arrhythmias in adults".)
●(See "Society guideline links: Inherited arrhythmia syndromes".)
●(See "Society guideline links: Cardiac implantable electronic devices".)
●(See "Society guideline links: Myocarditis".)
●(See "Society guideline links: Catheter ablation of arrhythmias".)
International
●International Liaison Committee on Resuscitation (ILCOR): International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations (2022)
•Advanced life support
•Basic life support
●Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA): Expert consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors – Facilities and patient management (2011, reaffirmed 2021)
●HRS/European Heart Rhythm Association (EHRA)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS): Expert consensus statement on catheter ablation of ventricular arrhythmias (2019)
●HRS/EHRA/APHRS/LAHRS: Focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing (2019)
●American Heart Association (AHA)/American College of Cardiology (ACC)/HRS: 2017 guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (published 2018)
●EHRA/HRS/APHRS: Expert consensus on ventricular arrhythmias (2014)
●HRS: Expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis (2014)
●Pediatric and Congenital Electrophysiology Society (PACES)/HRS: Consensus statement on the recognition and management of arrhythmias in adult congenital heart disease (2014)
●HRS/EHRA/APHRS: Expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes (2013)
●EHRA/HRS: Expert consensus statement on cardiac resynchronization therapy in heart failure – Implant and follow-up recommendations and management (2012)
Canada
●Canadian Cardiovascular Society (CCS)/Canadian Heart Rhythm Society (CHRS): Position statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease (2020)
●CCS/CHRS: 2016 implantable cardioverter-defibrillator guidelines (published 2017)
●CCS: Guidelines on the use of cardiac resynchronization therapy – Evidence and patient selection (2013)
●CCS: Guidelines on the use of cardiac resynchronization therapy – Implementation (2013)
●CCS/CHRS: Society position statement on recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death (2011)
United States
●American Heart Association (AHA): A scientific statement on arrhythmias in repaired tetralogy of Fallot (2022)
●Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA): Expert consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors – Facilities and patient management (2011, reaffirmed 2021)
●AHA: Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care – Part 3: Adult basic and advanced life support (2020)
●AHA: Scientific statement on device therapy and arrhythmia management in left ventricular assist device recipients (2019)
●AHA/American College of Cardiology (ACC)/HRS: 2017 guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (published 2018)
●AHA: Science advisory on (2016)
●AHA/ACC: Scientific statement on eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities – Arrhythmias and conduction defects (2015)
●AHA/ACC: Guideline for the management of patients with non-ST-elevation acute coronary syndromes (2014)
●Pediatric and Congenital Electrophysiology Society (PACES)/HRS: Consensus statement on the recognition and management of arrhythmias in adult congenital heart disease (2014)
●American College of Cardiology Foundation (ACCF)/AHA: Guideline for the management of ST-elevation myocardial infarction (2013)
●ACCF/HRS/AHA/American Society of Echocardiography (ASE)/Heart Failure Society of America (HFSA)/Society for Cardiovascular Angiography and Interventions (SCAI)/Society of Cardiovascular Computed Tomography (SCCT)/Society for Cardiovascular Magnetic Resonance (SCMR): Appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy (2013)
Europe
●European Society of Cardiology (ESC): Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2022)
●ESC: Guidelines on cardiac pacing and cardiac resynchronization therapy (2021)
●ESC: Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions – Part 2: Ventricular arrhythmias, channelopathies, and implantable defibrillators (2020)
●European Heart Rhythm Association (EHRA): Consensus document on cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization (2019)
●EHRA: Consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient (2019)
●EHRA: Consensus document on management of asymptomatic arrhythmias (2019)
●Heart Rhythm Society (HRS)/EHRA/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS): Expert consensus statement on catheter ablation of ventricular arrhythmias (2019)
●HRS/EHRA/APHRS/LAHRS: Focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing (2019)
●EHRA: Consensus document on sex differences in cardiac arrhythmia (2018)
●EHRA, Association for European Paediatric and Congenital Cardiology (AEPC), and ESC: Position paper on arrhythmias in congenital heart disease (2018)
●EHRA/Acute Cardiovascular Care Association (ACCA)/European Association of Percutaneous Cardiovascular Interventions (EAPCI): Position paper on cardiac arrhythmias in acute coronary syndromes (2014)
●EHRA/HRS/APHRS: Expert consensus on ventricular arrhythmias (2014)
●HRS/EHRA/APHRS: Expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes (2013)
●EHRA/HRS: Expert consensus statement on cardiac resynchronization therapy in heart failure – Implant and follow-up recommendations and management (2012)
●EHRA: A position paper on management of patients with palpitations (2011)
United Kingdom
●Resuscitation Council UK (RC): Adult advanced life support guidelines – Peri-arrest arrhythmias (2021)
●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on cardiac arrhythmias in coronary heart disease (2019)
●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance on subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death (2017)
●NICE: Interventional procedures guidance on percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia (2009)
Australia–New Zealand
●Australian Resuscitation Council (ARC) and New Zealand Resuscitation Council: Guideline 11.9 – Managing acute dysrhythmias
●Cardiac Society of Australia and New Zealand (CSANZ): Position statement on the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy, update (2019)
●CSANZ: Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia (CPVT) (2016)
Japan
●[In Japanese] Japanese Circulation Society (JCS)/Japanese Heart Rhythm Society (JHRS): Guideline on diagnosis and risk assessment of arrhythmia (2022)
●[In Japanese] JCS/JHRS: Guideline on non-pharmacotherapy of cardiac arrhythmias, focused update (2021)
●[In Japanese] JCS/JHRS: Guideline on pharmacotherapy of cardiac arrhythmias (2020)
